calmidazolium has been researched along with Innate Inflammatory Response in 1 studies
calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Montezano, AC | 1 |
Burger, D | 1 |
Paravicini, TM | 1 |
Chignalia, AZ | 1 |
Yusuf, H | 1 |
Almasri, M | 1 |
He, Y | 1 |
Callera, GE | 1 |
He, G | 1 |
Krause, KH | 1 |
Lambeth, D | 1 |
Quinn, MT | 1 |
Touyz, RM | 1 |
1 other study available for calmidazolium and Innate Inflammatory Response
Article | Year |
---|---|
Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
Topics: Angiotensin II; Calcium; Calcium Channel Blockers; Calmodulin; Cells, Cultured; Diltiazem; Endotheli | 2010 |